Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2, Pharmaceutical 2016
Albany, New York, Jan 19,2017 "Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2016" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Pipeline Review, H2 2016, provides an overview of the Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) (Metabolic Disorders) pipeline landscape. Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a condition that affects many different parts of the body and occurs almost exclusively in males. Signs and symptoms include claw-like hands, protruding tongue, changing facial features, including thickening of the lips, tongue and nostrils and delayed development. Treatment includes bone marrow transplantation, enzyme therapy and gene therapy. Get Samp